The funding round is intended for the adaptation of the in vitro diagnostic kit - Immunobiogram® (currently tested under a clinical trial with renal transplanted patients) for application in the field of Rheumatoid Arthritis. The company's pre-money valuation is 8,200,000 euros and it offers an exit in 2027 with ROE estimated at 508.72% and TAE at 45.41%. The [...]
The Project Management Institute starts a collaboration with Biohope for the dissemination of the company’s project
PMI (Project Management Institute) and Biohope have started to collaborate to find synergies between PMBoK and biomedicine project management. PMI is very interested in the diffusion on how a biomedicine project can be managed in each different knowledge area, and how specifics scientific risks can be monitored and mitigated by PMBoK methodology in a very [...]
BIOHOPE has successfully passed an admission process to join an Immersion Program at Boston Innovation Ecosystem at this Spring 2017 edition
The program is supported by “Richi Social Entrepreneurs”, an initiative from the Richi Foundation (USA) whose mission is to foster and catalyze the development of international Social Entrepreneurship ecosystems with profound impact on society, by improving health care standards and quality of life. Boston hosts a world-leading and successful model of high technology R+D at [...]
The in force agreement aims to establish the basis for a mutual collaboration and benefit promoting development of research projects and indutrial PhD oppotunities.